U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

First-Time Generics - March 2001

Drug Name ANDA Number  Approval Date
METHOTREXATE TABLETS, USP 5 MG 7.5 MG 10 MG 15 MG 40-385 3/21/01
BUTALBITAL, ACETAMINOPHEN & CAFFEINE WITH CODEINE PHOS. CAPS 50 MG/325 MG/40 MG/30 MG 75-618 3/23/01
BUSPIRONE HYDROCHLORIDE TABLETS, USP 7.5 MG 75-467 3/28/01
BUSPIRONE HYDROCHLORIDE TABLETS, USP 5 MG, 10 MG 10 MG 74-253 3/28/01
BUSPIRONE HYDROCHLORIDE TABLETS, USP 15 MG 75-272 3/28/01
LEVOCARNITINE INJECTION, USP 200 MG/ML (500 MG/2.5 ML) (1 G/5 ML) (2.5 G/12.5 ML) VIALS    

totop.gif (1525 bytes) Back to Top   Back Back to Approvals

FDA/Center for Drug Evaluation and Research
Last Updated: September 10, 2001
Originator: OGC
HTML by PKS, TA